Cell cycle regulation of human pancreatic cancer by tamoxifen
- 67 Downloads
Background: Clinical trials have suggested a survival advantage for selected patients with metastatic pancreatic cancer treated with tamoxifen. We sought to identify the molecular mechanism by which tamoxifen inhibits human pancreatic cancer cell (HPCC) growth.
Methods: HPCCs were grown in tamoxifen and growth inhibition was determined by3H-thymidine uptake and by the MTT assay; changes in cell viability were determined by cell counts. Cell cycle alterations were evaluated by FACS, and the induction of apoptosis was evaluated using the TUNEL assay. Total cellular RNA was isolated after tamoxifen treatment, and Northern blot analysis was performed for p21 waf1 .
Results: Tamoxifen inhibited HPCC growth as measured by inhibition of3H-thymidine incorporation and by the MTT assay. However, there was no decrease in the total number of viable cells after 6 days of treatment with 10 µM of tamoxifen and no evident apoptosis, confirming the absence of a cytotoxic effect. Cell cycle analysis revealed cellular arrest in the G0/G1 phase, which correlated with p21 waf1 mRNA upregulation in response to tamoxifen treatment.
Conclusions: Tamoxifen inhibits HPCC growth by inducing G0/G1 arrest with an associated increase in p21 waf1 mRNA expression. Tamoxifen is an effective inhibitor of HPCC growth in vitro and warrants further in vivo study.
Key WordsCell lines Apoptosis Cell cycle arrest p21waf1
Unable to display preview. Download preview PDF.
- 2.Benez C, Hollander C, Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity in human tumor cell lines.Cancer Res 1986;46:2276–81.Google Scholar
- 8.Bakkevold KE, Pettersen A, Arnesjo B, Espehaug B. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater.Br J Surg 1990;77:25–30.Google Scholar
- 9.Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.Mol Med 1995;1:505–26.Google Scholar
- 10.Danesi R, Figg WD, Reed E, Myers CE. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.Mol Pharm 1995;47:1106–11.Google Scholar
- 11.Jordon MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death.Cancer Res 1996;56:816–25.Google Scholar
- 13.Sambrook J, Fritsch E, Maniatis T. Synthesis of uniformly labeled DNA probes using random oligonucleotide primers. In: Nolan C, ed.Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Laboratory Press, 1989;2:10.13–5.Google Scholar
- 19.Ruggeeri B, Zhang S-Y, Caamano J, DiRado M, Flynn SD, Klein-Szanto AJP. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in p53 and Rb-1 tumor-suppressor genes.Oncogene 1992;7:1503–11.Google Scholar
- 20.Pan G, Ying W, Vickers SM, Phillips JO, McDonald JM. Involvement of the Fas/APO-1(CD95) in tamoxifen-induced apoptosis in cholangiocarcinoma.Proceedings of the American Association of Cancer Research 1997;38:625.Google Scholar
- 22.Greenway B, Iqbal M, Johnson P, Williams R. Oestrogen receptor proteins in malignant and fetal pancreas.Br Med J 1981;283:751–3.Google Scholar